Andrew “Mo” Septimus is an experienced entrepreneur with a track record of managing multimillion-dollar raises and budgets, complex projects and teams. He has worked in private equity and acted as chief financial officer (CFO) in various industries. Mo has been a life science executive for 10+ years beginning as CFO and cofounder of what became a subsidiary of IHI Inc. Mo was most recently the chief strategy officer at a biopharma subsidiary of Izun and CFO at Ebbu, a cannabis-focused biotech company that was sold to Canopy Growth Corp. Mo has been the CFO of Lykos Therapeutics since 2020. He received his B.S. in Finance and Agribusiness Economics from the University of Maryland.
Executive Committee